Anthem, Inc. (ANTM)
(Delayed Data from NYSE)
$261.70 USD
+0.11 (0.04%)
Updated May 3, 2019 04:00 PM ET
After-Market: $261.69 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$261.70 USD
+0.11 (0.04%)
Updated May 3, 2019 04:00 PM ET
After-Market: $261.69 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Based in Indianapolis, IN, and formed through the merger of Anthem Inc. and WellPoint Health Networks Inc. in Nov 2004, Anthem Inc. is one of the largest publicly traded managed care organizations in terms of membership. The company was previously named WellPoint Inc. (WLP). The company is also an independent licensee of the Blue Cross Blue Shield Association (BCBSA). Anthem is the largest BCBS plan provider in the United States. As of Mar 31, 2020, it catered to 42.1 million medical members through its affiliated health plans.
Here's Why Anthem (ANTM) is a Strong Value Stock
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Company News for Apr 21, 2022
by Zacks Equity Research
Companies In The News Are: PG, ABT, ANTM, BKR
Anthem (ANTM) Q1 Earnings Beat Estimates, Hikes '22 EPS View
by Zacks Equity Research
Anthem's (ANTM) first-quarter results indicate solid top-line growth and strong contribution from each of its businesses, partly offset by higher expenses.
Anthem (ANTM) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Anthem (ANTM) delivered earnings and revenue surprises of 5.63% and 1.40%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Average Family Health Insurance Premium Skyrockets During Affordable Care Act Era
by Bryan Hayes
The average family health insurance premium has risen nearly 60% since the 'Affordable' Care Act (ACA) was signed into law.
Anthem (ANTM) to Post Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Anthem's (ANTM) first-quarter results are likely to benefit from the growing premiums and an uptick in Medicare and Medicaid membership, partly offset by higher expenses.
Anthem (ANTM) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Anthem (ANTM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's How Investors Can Find Strong Medical Stocks with the Zacks ESP Screener
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Why Holding Anthem (ANTM) in Your Portfolio is a Prudent Move
by Zacks Equity Research
Riding high on better membership, a robust portfolio and operational excellence, Anthem (ANTM) holds potential to reap benefits for investors.
Anthem (ANTM) to be Renamed as Elevance Health for Rebranding
by Zacks Equity Research
Anthem (ANTM) intends to rename itself as Elevance Health to solidify its position in the market that goes beyond traditional insurance products.
Should You Invest in the Invesco S&P 500 Equal Weight Health Care ETF (RYH)?
by Zacks Equity Research
Sector ETF report for RYH
Is Invesco S&P 500 Equal Weight Health Care ETF (RYH) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for RYH
Anthem (ANTM) Rises 3.7% Since Q4 Earnings, Reiterates View
by Zacks Equity Research
Anthem's (ANTM) Medicaid footprint is likely to grow on the back of the pending acquisition of Paramount Advantage's Ohio contracts, as service is expected to commence in July.
Should You Invest in the iShares U.S. Healthcare Providers ETF (IHF)?
by Zacks Equity Research
Sector ETF report for IHF
Cigna (CI) Unveils '22 Capital Deployment Plans, Shares Up
by Zacks Equity Research
Cigna's (CI) shares gain on plans to deploy capital via share buybacks and targeted bolt-on acquisitions, which reflect its financial strength.
Anthem (ANTM) Up 1.4% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Anthem (ANTM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Select Medical (SEM) Q4 Earnings Beat on Higher Admissions
by Zacks Equity Research
Select Medical's (SEM) fourth-quarter results reflect solid revenues driven by robust contributions from all its segments, partly offset by higher costs and expenses.
Is Anthem (ANTM) a Suitable Value Investor Stock Now?
by Zacks Equity Research
Let's see if Anthem (ANTM) stock is a good choice for value-oriented investors right now from multiple angles.
Humana (HUM) Okays Dividend Hike, Boosts Shareholder Value
by Zacks Equity Research
Humana's (HUM) recent dividend hike highlights its sound financial position and sincere efforts to reward shareholders.
Humana (HUM) to Support Eligible Medicaid Members in Louisiana
by Zacks Equity Research
Humana (HUM) is picked by the Louisiana Department of Health for a contract win to help serve the Medicaid members in Louisiana.
Ensign Group (ENSG) Q4 Earnings Match Estimates, Rise Y/Y
by Zacks Equity Research
Ensign Group's (ENSG) Q4 results reflect higher revenues, partly offset by steep expenses.
Tenet Healthcare (THC) Q4 Earnings Beat Estimates, Surge Y/Y
by Zacks Equity Research
Tenet Healthcare (THC) Q4 results reflect lower expenses and operational efficiency along with a strong contribution from its Ambulatory Care segment.
Centene (CNC) Q4 Earnings Beat on Solid Membership Growth
by Zacks Equity Research
Centene's (CNC) fourth-quarter results indicate improved premium and service revenues coupled with sound membership growth. A solid 2022 guidance should impress investors.